Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma.
Wiechert
A
A
Tüting
T
T
Bieber
T
T
Haidl
G
G
Wenzel
J
J
D000287:Administration, Topical; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013472:Sunlight / Q000009:adverse effects; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide